Search research articles
Contact Us
Filters
Showing results (61-70 of 297) with videos related to
Page
of 30
Sort By:
Blood Advances
|
June 25, 2026
Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic Leukemia
Carol Fries, Lingyun Ji, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study
Richard H Ko, Lingyun Ji, Phillip Barnette, et al.
Blood
|
September 15, 2022
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study
Luke Maese, Mignon L Loh, Mi Rim Choi, et al.
Cancer Cell
|
October 7, 2008
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates
Nikesh Kotecha, Nikki J Flores, Jonathan M Irish, et al.
Blood Advances
|
May 2, 2022
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, et al.
Pediatric Blood & Cancer
|
September 13, 2023
Hemophagocytic lymphohistiocytosis and clonally related T-cell malignancies in a pediatric patient
Lauren K Meyer, Ingold Huang, Benjamin J Huang, et al.
Genome Biology
|
April 4, 2023
NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization
Sonali Narang, Nikki A Evensen, Jason Saliba, et al.
Cancers
|
January 8, 2025
The Proteomics of T-Cell and Early T-Cell Precursor (ETP) Acute Lymphocytic Leukemia: Prognostic Patterns in Adult and Pediatric-ETP ALL
Fieke W Hoff, Lourdes Sriraja, Yihua Qiu, et al.
Blood
|
February 21, 2014
PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML
Charles B Goodwin, Xing Jun Li, Raghuveer S Mali, et al.
Pediatric Blood & Cancer
|
July 27, 2010
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study
Matthew F Gorman, Lingyun Ji, Richard H Ko, et al.
Page
of 30
Search research articles
Search
Showing results (61-70 of 297) with videos related to
Sort By:
Page
of 30
Blood Advances
|
June 25, 2026
Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic Leukemia
Carol Fries, Lingyun Ji, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study
Richard H Ko, Lingyun Ji, Phillip Barnette, et al.
Blood
|
September 15, 2022
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study
Luke Maese, Mignon L Loh, Mi Rim Choi, et al.
Cancer Cell
|
October 7, 2008
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates
Nikesh Kotecha, Nikki J Flores, Jonathan M Irish, et al.
Blood Advances
|
May 2, 2022
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, et al.
Pediatric Blood & Cancer
|
September 13, 2023
Hemophagocytic lymphohistiocytosis and clonally related T-cell malignancies in a pediatric patient
Lauren K Meyer, Ingold Huang, Benjamin J Huang, et al.
Genome Biology
|
April 4, 2023
NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization
Sonali Narang, Nikki A Evensen, Jason Saliba, et al.
Cancers
|
January 8, 2025
The Proteomics of T-Cell and Early T-Cell Precursor (ETP) Acute Lymphocytic Leukemia: Prognostic Patterns in Adult and Pediatric-ETP ALL
Fieke W Hoff, Lourdes Sriraja, Yihua Qiu, et al.
Blood
|
February 21, 2014
PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML
Charles B Goodwin, Xing Jun Li, Raghuveer S Mali, et al.
Pediatric Blood & Cancer
|
July 27, 2010
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study
Matthew F Gorman, Lingyun Ji, Richard H Ko, et al.
Page
of 30